Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 6/20 | 0.47 |
| ▸ | TK1 | P04183 | 5/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25400388 | 1.00 | TOP2A (0.47) | TOP2ATK1HDAC1 | |
| SCHEMBL25400182 | 0.92 | TK1 (0.45) | TOP2ATK1 | |
| SCHEMBL26274379 | 0.92 | TK1 (0.45) | TOP2ATK1 | |
| SCHEMBL25399164 | 0.90 | LMNA (0.40) | TOP2ATK1HDAC1 | |
| SCHEMBL26273532 | 0.90 | LMNA (0.40) | TOP2ATK1HDAC1 | |
| SCHEMBL25399901 | 0.88 | TOP2A (0.46) | TOP2ATK1HDAC1 | |
| SCHEMBL25399479 | 0.88 | TOP2A (0.47) | TOP2ATK1 | |
| SCHEMBL9548691 | 0.85 | TK1 (0.46) | TOP2ATK1 | |
| SCHEMBL12942600 | 0.85 | TK1 (0.46) | TOP2ATK1 | |
| SCHEMBL9548698 | 0.85 | TK1 (0.46) | TOP2ATK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374058-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS, INC. | 2023-11-23 | — | — | US | disclosed |
| WO-2023178133-A9 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230295212-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | ROME THERAPEUTICS INC (US) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295212-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | EHMT1, POLRMT, RNASE1 | TOP2A 228/4885TK1 37/4885HDAC1 69/4885 |
| US-20230374058-A1 | COMPOUNDS AND METHODS FOR TREATING DISEASE | EHMT1, POLRMT, RNASE1 | TOP2A 228/4885TK1 37/4885HDAC1 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.